GO:0034705 potassium channel complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034705 (potassium channel complex) is a cellular component term describing any macromolecular assembly that mediates selective potassium ion flux across membranes.
• Potassium channel complexes are formed by pore-forming alpha subunits, often assembled with auxiliary beta subunits that modify gating, trafficking, and pharmacology.
• Dysfunction of potassium channel complexes underlies diseases including cardiac arrhythmias, neurological disorders, and cancer.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential for dissecting subunit-specific contributions to channel function.
• Advanced methods such as patch-clamp electrophysiology, proteomics, and CRISPR library screening enable high-resolution study of potassium channel complexes.
• EDITGENE provides custom cell models and screening services to accelerate research on potassium channel complex-related genes.
Description
Potassium channel complexes are fundamental membrane protein assemblies that control potassium ion flow across cellular membranes, thereby regulating membrane potential, excitability, and signaling. The Gene Ontology term GO:0034705 (potassium channel complex) captures the cellular component aspect of these assemblies, encompassing the pore-forming subunits and associated auxiliary proteins that together form a functional channel. Understanding the composition and regulation of potassium channel complexes is critical because they are involved in diverse physiological processes, from cardiac rhythm to neuronal firing and immune cell activation. Dysregulation of these complexes has been linked to numerous human diseases, including arrhythmias, epilepsy, and cancer. Researchers studying potassium channel complexes require reliable experimental models to dissect subunit contributions, trafficking, and pharmacology. This article provides a comprehensive overview of the ontology, structure, function, and research methodologies for GO:0034705, with a focus on CRISPR-based approaches for gene editing and cell model generation.
potassium channel complex At A Glance
| GO ID | GO:0034705 |
|---|---|
| GO term | potassium channel complex |
| Ontology | cellular_component |
| Synonym | none listed |
| Major function | Selective conduction of potassium ions across membranes |
| Major components | Pore-forming alpha subunits (e.g., Kv, Kir, KCa) and auxiliary beta subunits |
| Associated processes | Regulation of membrane potential, cell excitability, signal transduction |
| Disease relevance | Cardiac arrhythmias, neurological disorders, cancer, autoimmune diseases |
What Is GO:0034705?
GO:0034705, potassium channel complex, is a cellular component term that defines any protein complex that forms a potassium-selective ion channel. Such complexes typically consist of pore-forming alpha subunits, which may assemble as homo- or heterotetramers, and often include auxiliary beta subunits that modulate channel properties. The term encompasses the entire functional assembly required for potassium ion conduction across membranes.
Why Is potassium channel complex Important in Cell Biology?
Potassium channel complexes are essential for maintaining resting membrane potential and shaping action potentials in excitable cells, and they also play critical roles in non-excitable cells such as microglia and vascular smooth muscle. Their dysfunction is implicated in a wide range of pathologies, making them important therapeutic targets and research subjects.
• Regulate cardiac action potential duration and rhythm; mutations cause long QT syndrome and arrhythmias.
• Control neuronal excitability; dysfunction linked to epilepsy and neurodegenerative diseases.
• Modulate immune cell function; Kv1.3 is a target for autoimmune disease therapies.
• Influence vascular tone; potassium channel isoforms in smooth muscle affect blood pressure.
• Participate in glial cell function; Kir4.1 associates with dystrophin-glycoprotein complex in glia.
• Are targets for drugs treating diabetes, hypertension, and multiple sclerosis.
• Serve as models for studying protein trafficking and supertrafficking diseases.
• Provide insights into evolutionary diversity of ion channel ontogeny.
Structure and Composition of potassium channel complex
Pore-forming alpha subunits
In simple terms: The main building blocks that create the hole for potassium ions to pass through.
Potassium channel complexes are built from pore-forming alpha subunits that typically assemble as tetramers. These subunits contain the selectivity filter and voltage-sensing domains in voltage-gated channels. The alpha subunits determine the basic conduction properties and are encoded by genes such as KCNA, KCNB, KCNC, and KCNH families.
Auxiliary beta subunits
In simple terms: Helper proteins that attach to the main channel and tweak its behavior.
Auxiliary beta subunits, such as KCNE and KCNQ families, associate with alpha subunits to modulate gating, trafficking, and pharmacology. For example, KCNE4 modulates Kv1.3 pharmacology and trafficking. These subunits can alter channel sensitivity to drugs and toxins, and their tissue-specific expression contributes to functional diversity.
Assembly and trafficking
In simple terms: How the parts come together and move to the cell surface.
Assembly of potassium channel complexes occurs in the endoplasmic reticulum, where subunits fold and oligomerize. Proper trafficking to the plasma membrane requires chaperones and targeting signals. Disease-linked mutations can cause supertrafficking, leading to excessive channel surface expression.
Association with other proteins
In simple terms: Channels often stick to other proteins that anchor or regulate them.
Potassium channel complexes can associate with cytoskeletal and scaffolding proteins. For instance, Kir4.1 binds to the dystrophin-glycoprotein complex via alpha-syntrophin in glial cells, linking channel localization to cell structure. Such interactions are critical for proper channel function and localization.
Key Genes Involved in GO:0034705 potassium channel complex
The following genes encode major subunits and regulators of potassium channel complexes, with representative roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KCNA1 | Voltage-gated K+ channel alpha subunit (Kv1.1) | Episodic ataxia, neuronal excitability |
| KCNA3 | Voltage-gated K+ channel alpha subunit (Kv1.3) | Autoimmune diseases, T cell activation |
| KCNB1 | Voltage-gated K+ channel alpha subunit (Kv2.1) | Epileptic encephalopathy |
| KCNC1 | Voltage-gated K+ channel alpha subunit (Kv3.1) | Progressive myoclonus epilepsy |
| KCNH2 | Voltage-gated K+ channel alpha subunit (hERG) | Long QT syndrome, drug safety |
| KCNQ1 | Voltage-gated K+ channel alpha subunit (Kv7.1) | Long QT syndrome, deafness |
| KCNE1 | Auxiliary beta subunit (minK) | Long QT syndrome, channel modulation |
| KCNE4 | Auxiliary beta subunit | Modulation of Kv1.3 pharmacology |
| KCNJ2 | Inwardly rectifying K+ channel (Kir2.1) | Andersen-Tawil syndrome |
| KCNJ10 | Inwardly rectifying K+ channel (Kir4.1) | Glial function, epilepsy |
| KCNMA1 | Calcium-activated K+ channel alpha subunit (BK) | Epilepsy, hypertension |
| KCNN4 | Calcium-activated K+ channel (KCa3.1) | Immune disorders, sickle cell disease |
| KCNQ2 | Voltage-gated K+ channel alpha subunit (Kv7.2) | Benign familial neonatal seizures |
| KCNQ3 | Voltage-gated K+ channel alpha subunit (Kv7.3) | Benign familial neonatal seizures |
| KCNH1 | Voltage-gated K+ channel alpha subunit (Kv10.1) | Temple-Baraitser syndrome |
| KCNT1 | Sodium-activated K+ channel (Slack) | Epilepsy of infancy with migrating focal seizures |
| KCNJ11 | Inwardly rectifying K+ channel (Kir6.2) | Neonatal diabetes, hyperinsulinism |
How Is potassium channel complex Regulated?
Potassium channel complex activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and interaction with auxiliary subunits. Phosphorylation by kinases such as protein kinase A and C can modulate gating properties. Auxiliary subunits like KCNE4 alter trafficking and pharmacology. Additionally, disease-linked mutations can cause supertrafficking, increasing surface expression. These regulatory mechanisms are critical for fine-tuning cellular excitability.
potassium channel complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNH2 | Long QT syndrome | Knockout or point mutation in cardiomyocytes |
| KCNA3 | Autoimmune diseases | Knockout in T cells or overexpression in cell lines |
| KCNJ10 | Epilepsy, glial dysfunction | Knock-in of patient mutations in astrocytes |
| KCNQ1 | Long QT syndrome, deafness | Knockout in induced pluripotent stem cell-derived cardiomyocytes |
| KCNE4 | Modulation of Kv1.3 pharmacology | Overexpression in HEK293 cells for electrophysiology |
Cardiac arrhythmias
Mutations in potassium channel complex genes, such as KCNH2 and KCNQ1, cause long QT syndrome and other arrhythmias by altering repolarization. These channelopathies highlight the importance of proper complex assembly and function.
Neurological disorders
Dysfunction of potassium channel complexes in neurons leads to epilepsy, episodic ataxia, and neurodegenerative conditions. For example, mutations in KCNA1 cause episodic ataxia type 1, and KCNC1 mutations are linked to progressive myoclonus epilepsy.
Autoimmune and inflammatory diseases
Kv1.3 potassium channel complexes are critical for T cell activation and are targets for immunosuppressive drugs. KCNE4 modulation of Kv1.3 pharmacology affects T cell function, making it a potential therapeutic target.
Glial and vascular disorders
Kir4.1 (KCNJ10) associates with the dystrophin-glycoprotein complex in glia, and its dysfunction contributes to epilepsy and retinal disorders. Vascular potassium channel isoforms regulate smooth muscle tone and blood pressure.
From potassium channel complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of a specific channel gene knockout on membrane potential? | CRISPR knockout cell line (e.g., HEK293, primary neurons) |
| How does a disease-associated point mutation alter channel gating? | CRISPR point mutation knock-in cell line |
| What is the role of a subunit in channel trafficking? | Knock-in of tagged channel subunit for imaging |
| Can overexpression of a channel gene rescue a phenotype? | CRISPR overexpression (e.g., CRISPRa) in cell models |
| Which genes modulate channel function in a high-throughput setting? | CRISPR library screening in relevant cell types |
| How does a channel complex interact with other proteins? | Proteomics with tagged knock-in subunits |
How to Study the potassium channel complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion currents, gating, pharmacology | Functional characterization of channel mutants |
| CRISPR knockout screening | Gene essentiality for channel function | Identification of novel regulators |
| Proteomics (AP-MS) | Protein-protein interactions | Mapping channel complex interactome |
| Live-cell imaging | Trafficking and localization | Studying supertrafficking mutants |
| RNA-seq | Transcriptional changes | Evaluating expression of channel genes |
| Western blot | Protein expression levels | Validating knockout or overexpression |
| Immunoprecipitation | Complex assembly | Detecting subunit interactions |
| Flow cytometry | Surface expression | Quantifying channel trafficking |
Electrophysiology
Patch-clamp electrophysiology is the gold standard for measuring potassium channel activity, including gating, conductance, and pharmacology. It allows real-time assessment of channel function in live cells.
CRISPR-based genetic screens
CRISPR knockout and activation libraries enable unbiased discovery of genes that regulate potassium channel complex function or trafficking. These screens can identify novel modulators and disease targets.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify components and interacting partners of potassium channel complexes. This approach reveals the broader protein network associated with the channel.
Imaging and trafficking assays
Fluorescence microscopy with tagged subunits allows visualization of channel assembly, trafficking, and surface expression. Super-resolution techniques can resolve subcellular localization.
How CRISPR Can Be Used to Study GO:0034705 potassium channel complex
Knockout
CRISPR knockout of potassium channel genes eliminates specific subunits, allowing researchers to study their contribution to channel function and cellular excitability. For example, knockout of KCNA3 in T cells can reveal its role in immune activation.
Point Mutation
Introducing disease-associated point mutations via CRISPR allows precise modeling of channelopathies. This helps dissect how single amino acid changes alter gating, trafficking, or drug sensitivity.
Knock-in
Knock-in of tagged or reporter genes enables visualization and purification of channel complexes. This is useful for studying assembly, trafficking, and interactions with other proteins.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression can increase channel subunit levels to study gain-of-function effects or rescue phenotypes. Overexpression of KCNE4, for instance, modulates Kv1.3 pharmacology.
How EDITGENE Supports potassium channel complex Research
Researchers studying potassium channel complex-related genes often need to determine whether a candidate gene is causally involved in channel function, trafficking, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for potassium channel complex research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| KCNQ1 Knockout HEK293 Cell Line | EDJ-KQ2359 | Human | 3784 | Details Get a Quote |
| KCNK1 Knockout HEK293 Cell Line | EDJ-KQ4262 | Human | 3775 | Details Get a Quote |
| KCNA2 Knockout HEK293 Cell Line | EDJ-KQ5014 | Human | 3737 | Details Get a Quote |
| KCNA5 Knockout HEK293 Cell Line | EDJ-KQ5016 | Human | 3741 | Details Get a Quote |
| KCNA6 Knockout HEK293 Cell Line | EDJ-KQ5017 | Human | 3742 | Details Get a Quote |
| KCNAB1 Knockout HEK293 Cell Line | EDJ-KQ6140 | Human | 7881 | Details Get a Quote |
| AKAP9 Knockout HEK293 Cell Line | EDJ-KQ6912 | Human | 10142 | Details Get a Quote |
| KCNK4 Knockout HEK293 Cell Line | EDJ-KQ10808 | Human | 50801 | Details Get a Quote |
| CCDC51 Knockout HEK293 Cell Line | EDJ-KQ12756 | Human | 79714 | Details Get a Quote |
| KCNK1 Knockout A-549 Cell Line | EDJ-KQ27956 | Human | 3775 | Details Get a Quote |
| KCNK1 Knockout HCT 116 Cell Line | EDJ-KQ27957 | Human | 3775 | Details Get a Quote |
| KCNK1 Knockout HeLa Cell Line | EDJ-KQ27958 | Human | 3775 | Details Get a Quote |
| AKAP9 Knockout HeLa Cell Line | EDJ-KQ30171 | Human | 10142 | Details Get a Quote |
| KCNQ1 Knockout HCT 116 Cell Line | EDJ-KQ22798 | Human | 3784 | Details Get a Quote |
| KCNQ1 Knockout HeLa Cell Line | EDJ-KQ22799 | Human | 3784 | Details Get a Quote |
Displaying Records 1 To 15 Of 36 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About potassium channel complex
What is GO:0034705?
GO:0034705 is the Gene Ontology term for potassium channel complex, a cellular component comprising proteins that form a potassium-selective ion channel.
What genes are involved in potassium channel complex?
Genes encoding alpha subunits (e.g., KCNA1, KCNH2, KCNQ1) and beta subunits (e.g., KCNE1, KCNE4) are key components.
What diseases are associated with potassium channel complex dysfunction?
Diseases include long QT syndrome, epilepsy, autoimmune disorders, and some cancers.
How can I study potassium channel complex in the lab?
Common methods include patch-clamp electrophysiology, CRISPR knockout, proteomics, and imaging.
What is the role of auxiliary subunits in potassium channel complex?
Auxiliary subunits modulate gating, trafficking, and pharmacology of the channel complex.
Can CRISPR be used to model potassium channel diseases?
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to study channelopathies.
What is supertrafficking in potassium channel complexes?
Supertrafficking refers to excessive trafficking of channels to the cell surface, which can be caused by disease-linked mutations.
How does Kir4.1 associate with glial cells?
Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia, influencing potassium homeostasis.
What is the significance of Kv1.3 in immunology?
Kv1.3 is a potassium channel complex critical for T cell activation and is a target for immunosuppressive drugs.
What services does EDITGENE offer for potassium channel research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
Potassium channel complexes (GO:0034705) are essential membrane protein assemblies that regulate diverse physiological processes and are implicated in numerous diseases. Understanding their structure, function, and regulation requires advanced experimental models. CRISPR-based approaches offer powerful tools to dissect subunit contributions and disease mechanisms. EDITGENE's comprehensive services support researchers in generating precisely engineered cell models to accelerate discoveries in potassium channel biology.
References
- 1. Deutsch C. 2002. Potassium channel ontogeny.. Annu Rev Physiol 64:19-46 PMID: 11826262
- 2. Catterall W et al.. 1992. Ion channels.. Diabetologia 35 Suppl 2:S23-33 PMID: 1282478
- 3. Huang H et al.. 2021. Disease-linked supertrafficking of a potassium channel.. J Biol Chem 296:100423 PMID: 33600800
- 4. Armstrong CM. 2003. Voltage-gated K channels.. Sci STKE 2003(188):re10 PMID: 12824476
- 5. Nguyen HM et al.. 2017. Potassium channel expression and function in microglia: Plasticity and possible species variations.. Channels (Austin) 11(4):305-315 PMID: 28277939
- 6. Korovkina VP et al.. 2002. Molecular diversity of vascular potassium channel isoforms.. Clin Exp Pharmacol Physiol 29(4):317-23 PMID: 11985543
- 7. Connors NC et al.. 2004. The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia.. J Biol Chem 279(27):28387-92 PMID: 15102837
- 8. Sastre D et al.. 2024. KCNE4-dependent modulation of Kv1.3 pharmacology.. Biochem Pharmacol 226:116368 PMID: 38880360
